+データを開く
-基本情報
登録情報 | データベース: PDB / ID: 1ums | ||||||
---|---|---|---|---|---|---|---|
タイトル | STROMELYSIN-1 CATALYTIC DOMAIN WITH HYDROPHOBIC INHIBITOR BOUND, PH 7.0, 32OC, 20 MM CACL2, 15% ACETONITRILE; NMR ENSEMBLE OF 20 STRUCTURES | ||||||
要素 | STROMELYSIN-1 | ||||||
キーワード | HYDROLASE/HYDROLASE INHIBITOR / ZINC HYDROLASE / METZINCIN / MATRIX METALLOPROTEINASE / HYDROLASE-HYDROLASE INHIBITOR COMPLEX | ||||||
機能・相同性 | 機能・相同性情報 stromelysin 1 / cellular response to UV-A / regulation of neuroinflammatory response / Assembly of collagen fibrils and other multimeric structures / Activation of Matrix Metalloproteinases / response to amyloid-beta / Collagen degradation / collagen catabolic process / negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction / extracellular matrix disassembly ...stromelysin 1 / cellular response to UV-A / regulation of neuroinflammatory response / Assembly of collagen fibrils and other multimeric structures / Activation of Matrix Metalloproteinases / response to amyloid-beta / Collagen degradation / collagen catabolic process / negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction / extracellular matrix disassembly / cellular response to nitric oxide / negative regulation of reactive oxygen species metabolic process / EGFR Transactivation by Gastrin / Degradation of the extracellular matrix / regulation of cell migration / extracellular matrix organization / extracellular matrix / cellular response to amino acid stimulus / positive regulation of protein-containing complex assembly / protein catabolic process / metalloendopeptidase activity / cellular response to reactive oxygen species / metallopeptidase activity / peptidase activity / cellular response to lipopolysaccharide / Interleukin-4 and Interleukin-13 signaling / endopeptidase activity / Extra-nuclear estrogen signaling / innate immune response / serine-type endopeptidase activity / mitochondrion / proteolysis / extracellular space / zinc ion binding / extracellular region / nucleus / cytosol 類似検索 - 分子機能 | ||||||
生物種 | Homo sapiens (ヒト) | ||||||
手法 | 溶液NMR | ||||||
データ登録者 | Van Doren, S.R. / Kurochkin, A.V. / Hu, W. / Zuiderweg, E.R.P. | ||||||
引用 | ジャーナル: Protein Sci. / 年: 1995 タイトル: Solution structure of the catalytic domain of human stromelysin complexed with a hydrophobic inhibitor. 著者: Van Doren, S.R. / Kurochkin, A.V. / Hu, W. / Ye, Q.Z. / Johnson, L.L. / Hupe, D.J. / Zuiderweg, E.R. #1: ジャーナル: Biochemistry / 年: 1993 タイトル: Assignments for the Main-Chain Nuclear Magnetic Resonances and Delineation of the Secondary Structure of the Catalytic Domain of Human Stromelysin-1 as Obtained from Triple-Resonance 3D NMR Experiments 著者: Van Doren, S.R. / Kurochkin, A.V. / Ye, Q.-Z. / Johnson, L.L. / Hupe, D.J. / Zuiderweg, E.R.P. | ||||||
履歴 |
|
-構造の表示
構造ビューア | 分子: MolmilJmol/JSmol |
---|
-ダウンロードとリンク
-ダウンロード
PDBx/mmCIF形式 | 1ums.cif.gz | 1 MB | 表示 | PDBx/mmCIF形式 |
---|---|---|---|---|
PDB形式 | pdb1ums.ent.gz | 859.3 KB | 表示 | PDB形式 |
PDBx/mmJSON形式 | 1ums.json.gz | ツリー表示 | PDBx/mmJSON形式 | |
その他 | その他のダウンロード |
-検証レポート
文書・要旨 | 1ums_validation.pdf.gz | 458.3 KB | 表示 | wwPDB検証レポート |
---|---|---|---|---|
文書・詳細版 | 1ums_full_validation.pdf.gz | 733.2 KB | 表示 | |
XML形式データ | 1ums_validation.xml.gz | 117.5 KB | 表示 | |
CIF形式データ | 1ums_validation.cif.gz | 140 KB | 表示 | |
アーカイブディレクトリ | https://data.pdbj.org/pub/pdb/validation_reports/um/1ums ftp://data.pdbj.org/pub/pdb/validation_reports/um/1ums | HTTPS FTP |
-関連構造データ
-リンク
-集合体
登録構造単位 |
| |||||||||
---|---|---|---|---|---|---|---|---|---|---|
1 |
| |||||||||
Atom site foot note | 1: CIS PROLINE - PRO A 87 MODEL 1 / 2: CIS PROLINE - PRO A 109 MODEL 1 3: THR A 128 - PRO A 129 MODEL 1 OMEGA = 140.08 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 4: TYR A 155 - PRO A 156 MODEL 1 OMEGA = 211.20 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 5: TYR A 220 - PRO A 221 MODEL 1 OMEGA = 220.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 6: CIS PROLINE - PRO A 87 MODEL 2 7: THR A 128 - PRO A 129 MODEL 2 OMEGA = 140.45 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 8: CIS PROLINE - PRO A 87 MODEL 3 9: THR A 128 - PRO A 129 MODEL 3 OMEGA = 137.29 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 10: TYR A 220 - PRO A 221 MODEL 3 OMEGA = 229.78 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 11: THR A 128 - PRO A 129 MODEL 4 OMEGA = 131.14 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 12: TYR A 155 - PRO A 156 MODEL 4 OMEGA = 218.19 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 13: GLY A 159 - PRO A 160 MODEL 4 OMEGA = 222.63 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 14: ALA A 169 - PRO A 170 MODEL 4 OMEGA = 245.06 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 15: CIS PROLINE - PRO A 87 MODEL 5 16: THR A 128 - PRO A 129 MODEL 5 OMEGA = 143.79 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 17: CIS PROLINE - PRO A 87 MODEL 6 18: THR A 128 - PRO A 129 MODEL 6 OMEGA = 136.67 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 19: TYR A 220 - PRO A 221 MODEL 6 OMEGA = 225.35 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 20: CIS PROLINE - PRO A 87 MODEL 7 21: THR A 128 - PRO A 129 MODEL 7 OMEGA = 141.81 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 22: CIS PROLINE - PRO A 172 MODEL 7 23: TYR A 220 - PRO A 221 MODEL 7 OMEGA = 229.18 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 24: CIS PROLINE - PRO A 87 MODEL 8 25: ILE A 89 - PRO A 90 MODEL 8 OMEGA = 223.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 26: THR A 128 - PRO A 129 MODEL 8 OMEGA = 143.14 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 27: GLY A 159 - PRO A 160 MODEL 8 OMEGA = 221.57 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 28: CIS PROLINE - PRO A 90 MODEL 9 / 29: CIS PROLINE - PRO A 87 MODEL 10 30: THR A 128 - PRO A 129 MODEL 10 OMEGA = 137.84 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 31: CIS PROLINE - PRO A 87 MODEL 11 32: ILE A 89 - PRO A 90 MODEL 11 OMEGA = 148.36 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 33: THR A 128 - PRO A 129 MODEL 11 OMEGA = 143.18 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 34: CIS PROLINE - PRO A 87 MODEL 12 35: THR A 128 - PRO A 129 MODEL 12 OMEGA = 141.31 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 36: GLY A 159 - PRO A 160 MODEL 12 OMEGA = 214.44 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 37: CIS PROLINE - PRO A 87 MODEL 13 38: THR A 128 - PRO A 129 MODEL 13 OMEGA = 139.16 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 39: TYR A 155 - PRO A 156 MODEL 13 OMEGA = 255.71 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 40: ALA A 169 - PRO A 170 MODEL 13 OMEGA = 305.81 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 41: TYR A 220 - PRO A 221 MODEL 13 OMEGA = 221.23 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 42: CIS PROLINE - PRO A 87 MODEL 14 43: THR A 128 - PRO A 129 MODEL 14 OMEGA = 137.86 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 44: TYR A 220 - PRO A 221 MODEL 14 OMEGA = 225.10 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 45: CIS PROLINE - PRO A 87 MODEL 15 46: THR A 128 - PRO A 129 MODEL 15 OMEGA = 142.51 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 47: CIS PROLINE - PRO A 87 MODEL 16 48: THR A 128 - PRO A 129 MODEL 16 OMEGA = 141.90 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 49: TYR A 155 - PRO A 156 MODEL 16 OMEGA = 256.07 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 50: CIS PROLINE - PRO A 87 MODEL 17 51: ILE A 89 - PRO A 90 MODEL 17 OMEGA = 239.90 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 52: THR A 128 - PRO A 129 MODEL 17 OMEGA = 139.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 53: CIS PROLINE - PRO A 172 MODEL 17 / 54: CIS PROLINE - PRO A 87 MODEL 18 55: THR A 128 - PRO A 129 MODEL 18 OMEGA = 137.94 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 56: CIS PROLINE - PRO A 156 MODEL 18 57: ALA A 169 - PRO A 170 MODEL 18 OMEGA = 319.53 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 58: CIS PROLINE - PRO A 172 MODEL 18 59: TYR A 220 - PRO A 221 MODEL 18 OMEGA = 235.68 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 60: CIS PROLINE - PRO A 87 MODEL 19 61: THR A 105 - PRO A 106 MODEL 19 OMEGA = 211.53 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 62: THR A 128 - PRO A 129 MODEL 19 OMEGA = 142.69 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 63: TYR A 155 - PRO A 156 MODEL 19 OMEGA = 243.41 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 64: CIS PROLINE - PRO A 87 MODEL 20 65: THR A 128 - PRO A 129 MODEL 20 OMEGA = 128.85 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 66: TYR A 220 - PRO A 221 MODEL 20 OMEGA = 230.10 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION | |||||||||
NMR アンサンブル |
|
-要素
#1: タンパク質 | 分子量: 19513.646 Da / 分子数: 1 / 断片: CATALYTIC DOMAIN RESIDUES 83 - 256 / 由来タイプ: 組換発現 / 由来: (組換発現) Homo sapiens (ヒト) / 解説: INDUCTION BY M13 WITH T7 RNA POLYMERASE / 遺伝子: HUMAN STROMELYSIN-1 CATALYTIC / プラスミド: PGEMEX-D 遺伝子 (発現宿主): HUMAN STROMELYSIN-1 CATALYTIC DOMAIN 発現宿主: Escherichia coli (大腸菌) / 参照: UniProt: P08254, stromelysin 1 | ||||
---|---|---|---|---|---|
#2: 化合物 | #3: 化合物 | ChemComp-CA / | #4: 化合物 | ChemComp-0DS / | |
-実験情報
-実験
実験 | 手法: 溶液NMR |
---|
-試料調製
結晶化 | *PLUS 手法: other |
---|
-解析
NMR software |
| |||||||||
---|---|---|---|---|---|---|---|---|---|---|
NMRアンサンブル | 登録したコンフォーマーの数: 20 |